Atossa Therapeutics CEO Dr Steven Quay joined Steve Darling from Proactive to share news the company has been granted, by the U.S. Patent office, a new patent directed to enterically encapsulated Endoxifen compositions formulated as a suspension. These will include all liquid suspension...…Atossa Therapeutics CEO Dr Steven Quay joined Steve Darling from Proactive to share news the company has been granted, by the U.S. Patent office, a new patent directed to enterically encapsulated Endoxifen compositions formulated as a suspension. These will include all liquid suspension...WW…

Nano One Materials Corp (TSX:NANO, OTC:NNOMF) COO Alex Holmes joined Steve Darling from Proactive to announced the company's partnership with Worley Chemetics through a Strategic Alliance Agreement and a License Agreement. The collaboration aims to jointly develop, market, and license a process...…Nano One Materials Corp (TSX:NANO, OTC:NNOMF) COO Alex Holmes joined Steve Darling from Proactive to announced the company's partnership with Worley Chemetics through a Strategic Alliance Agreement and a License Agreement. The collaboration aims to jointly develop, market, and license a process...WW…

Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share some groundbreaking news. The U.S. Food and Drug Administration (FDA) has given its approval for the Investigational New Drug application for PEX010, Filament Health's botanical psilocybin drug candidate designed for...…Filament Health CEO Ben Lightburn joined Steve Darling from Proactive to share some groundbreaking news. The U.S. Food and Drug Administration (FDA) has given its approval for the Investigational New Drug application for PEX010, Filament Health's botanical psilocybin drug candidate designed for...WW…